Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2014 / Cilt: 24 - Sayı: 2

Febril Nötropenik Pediatrik Onkoloji Hastalarında Donör Granülosit Transfüzyonları

Donor Granulocyte Transfusions in Febrile Neutropenic Pediatric Oncology Patients

Pages
75–81
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

GTFs were generally well tolerated and improve short-term outcome in neutropenic pediatric oncology patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To describe the clinical course of febrile neutropenic pediatric oncology patients undergoing granulocyte transfusions (GTF), we performed a retrospective chart review of all pediatric oncology patients with febrile neutropenia receiving granulocyte transfusions between September 2009 and September 2011 in a University Hospital setting.
📊
Key Findings & Data:Thirty-seven patients received a total of 51 courses of GTFs.
💡
Conclusion & Impact:GTFs were generally well tolerated and improve short-term outcome in neutropenic pediatric oncology patients.
🔬Design:Review & Systematic Survey
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

To describe the clinical course of febrile neutropenic pediatric oncology patients undergoing granulocyte transfusions (GTF), we performed a retrospective chart review of all pediatric oncology patients with febrile neutropenia receiving granulocyte transfusions between September 2009 and September 2011 in a University Hospital setting. Thirty-seven patients received a total of 51 courses of GTFs. In 35 febrile episodes patients had leukemia and in 16 episodes patients had solid tumors. Three patients received allogeneic hematopoietic stem cell transplantation from their HLA identical sibling. Mean duration of fever and neutropenia was 18.5±17.5 days. Infections were classified as fever of unknown origin (21%, n= 11), microbiologically documented infection (44%, n= 23), clinically suspected infection (35%, n= 18). The mean granulocyte yield, WBC count and granulocyte count of the products were 3.1±1.2x1010/unit, 158.6±66.4x103 /mm3 and 134.5±62x 103 /mm3 , respectively. The median donor WBC count at leukapheresis was 32.91x109 /L. GTFs were well tolerated except one patient who had fever during transfusion. Thirty-nine (76.5%) of the episodes resolved from infection and discharged from the hospital. Of the 12 patients (23.5%) who died, seven of them were refractory to treatment, three patients had relapsed disease and two patients had newly diagnosed disease. This case series documents the course of 37 septic neutropenic pediatric oncology patients who underwent a total of 51 GTF courses. GTFs were generally well tolerated and improve short-term outcome in neutropenic pediatric oncology patients.

Özet

Bu çalışmada febril nötropeni gelişen kanserli çocuk hastaların granülosit transfüzyonu sonrası klinik durumlarının izlenmesi amaçlandı. Eylül 2009 ile Eylül 2011 yılları arasında üniversite hastanesinde, nötropenik ateş nedeniyle granülosit tranfüzyonu verilen hastaların retrospektif olarak dosyaları incelenmiştir. Otuz yedi hasta toplam ellibir granülosit transfüzyonu almıştır. Febril atakların 35’inde lösemi, 16 atakta ise solid tümör tanısı mevcut idi. Üç hastaya HLA uygun kardeşten allojeneik kök hücre nakli yapılmış idi. Ortalama ateş ve nötropeni süresi 18.5±17.5 gün saptandı. Hastaların %21’inde (n= 11) sebebi bilinmeyen ateş, %44’ünde (n= 23) mikrobiyolojik olarak kanıtlanmış enfeksiyon, %35’inde (n= 18) klinik enfeksiyon vardı. Granülosit ürün verimi 3.1±1.2x1010/ünite, ortalama ürün beyaz küre sayısı 158.6±66.4x103 / mm3 ve ortalama ürün granülosit sayısı 134.5±62x 103 /mm3 bulundu. Lökaferezde vericinin ortanca beyaz küre sayısı 32.91x109 /L olarak saptandı. Granülosit transfüzyonları bir hastada transfüzyon sırasında gelişen ateş dışında iyi tolere edilmişti. Otuz dokuz atakta (%76.5) hastalar iyileşerek taburcu edilmiş; 12 (%23.5) atak sonrasında hasta kaybedilmiştir. Kaybedilen hastaların yedisinde refrakter hastalık, iki tanesi yeni tanı ve üçünde de relaps hastalık saptanmıştı. Bu makalede 51 granülosit transfüzyonu alan septik nötropenik 37 pediatrik onkoloji hastasının kliniği incelenmiştir. Granülosit transfüzyonlarının iyi tolere edildiği ve kısa dönemde sağkalımı iyi yönde etkilediği görülmüştür.

🔖

Cite This Article

SEZGİN, G., ACIPAYAM, C., TURHAN, F. T., ÖZKAN, A., KÜPELİ, S., BAYRAM, İ., GÜVENÇ, B., TANYELİ, A. (2014). Febril Nötropenik Pediatrik Onkoloji Hastalarında Donör Granülosit Transfüzyonları. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 24 - Sayı: 2, 75–81. https://ajindex.com/articles/322987

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Koh AY, Pizzo PA. Infectious complications in pediatric cancer patients: In Principles and Practice of Pediatric Oncology, 6th Ed, Pizzo PA, Poplack GA(eds), Lippincott, Williams &Wilkins, 2010: 1190-1242.
  2. Grigull L, Pulver N, Goudeva L, et al. G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer 14: 910-916, 2006.
  3. Cesaro S, Chinello P, De Silvestro G, et al. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with oncohematological diseases. Support Care Cancer 11: 101-106, 2003.
  4. Sachs UJ, Reiter A, Walter T, et al. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion 46: 1909- 1914, 2006.
  5. Hallahan A, Shaw P, Rowell G, et al. Improved outcomes of children with malignancy admitted to a pediatric intensive care unit. Crit Care Med 28: 3718-3721, 2000. Price TH. The current prospects for neutropil transfusions for the treatment of granulocytopenic infected patients. Transfus Med Rev 14: 2-11, 2000.
  6. Graw RG Jr, Herzig G, Perry S, et al. Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N Engl J Med 287: 367-371, 1972.
  7. Alavi JB, Root RK, Djerassi I, et al. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 296: 706-711, 1977.
  8. Vogler WR, Winton EF. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 63: 548-555, 1977.
  9. Herzig RH, Herzig GP, Graw RG Jr, et al. Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study. N Engl J Med 296: 701-705, 1977.
  10. Winston DJ, Ho WG, Gale RP. Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninetyfive infectious granulocytopenic episodes. Ann Intern Med 97: 509-515, 1982. Strauss RG. Therapeutic granulocyte transfusions. Blood 81: 1675-1678, 1993.
  11. Vamvakas EC, Pineda AA. Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apher 11: 1-9, 1996.
  12. Wright DG, Robichaud KJ, Pizzo PA, et al. Lethal pulmonary reactions asssociated with combined use of Amphotericin B and leukocyte transfusion. N Eng J Med 3041: 185-189, 1981
  13. Hübel K, Dale DC, Engert A, Liles WC. Current status of granulocyte (neutrophil) tra